Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
NCT ID: NCT04396119
Last Updated: 2020-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2020-02-11
2020-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Screening in People Cured of Hodgkin Lymphoma
NCT04986189
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559
Analysis of Screen-detected Lung Cancers' Genomic Traits
NCT04204499
Survival Outcomes of Lung Cancer
NCT03647098
Determining Clinical Trial Experiences of Lung Cancer Patients
NCT05760170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Responded to most recent ADAPT study questionnaire (April - August 2019)
* Aged 18-80
* Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years
* Able to provide informed consent
* Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy.
Exclusion Criteria
* Stated within 2019 health questionnaire that they did not wish to be contacted
* Have participated in lung cancer screening through the Manchester Lung Health Checks
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Christie NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christie NHS Foundation Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
276443
Identifier Type: OTHER
Identifier Source: secondary_id
CFTSp178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.